These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 31883238)

  • 1. Noonan syndrome-associated biallelic LZTR1 mutations cause cardiac hypertrophy and vascular malformations in zebrafish.
    Nakagama Y; Takeda N; Ogawa S; Takeda H; Furutani Y; Nakanishi T; Sato T; Hirata Y; Oka A; Inuzuka R
    Mol Genet Genomic Med; 2020 Mar; 8(3):e1107. PubMed ID: 31883238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutation-induced LZTR1 polymerization provokes cardiac pathology in recessive Noonan syndrome.
    Busley AV; Gutiérrez-Gutiérrez Ó; Hammer E; Koitka F; Mirzaiebadizi A; Steinegger M; Pape C; Böhmer L; Schroeder H; Kleinsorge M; Engler M; Cirstea IC; Gremer L; Willbold D; Altmüller J; Marbach F; Hasenfuss G; Zimmermann WH; Ahmadian MR; Wollnik B; Cyganek L
    Cell Rep; 2024 Jul; 43(7):114448. PubMed ID: 39003740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dominant Noonan syndrome-causing LZTR1 mutations specifically affect the Kelch domain substrate-recognition surface and enhance RAS-MAPK signaling.
    Motta M; Fidan M; Bellacchio E; Pantaleoni F; Schneider-Heieck K; Coppola S; Borck G; Salviati L; Zenker M; Cirstea IC; Tartaglia M
    Hum Mol Genet; 2019 Mar; 28(6):1007-1022. PubMed ID: 30481304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Noonan Syndrome Gene
    Sewduth RN; Pandolfi S; Steklov M; Sheryazdanova A; Zhao P; Criem N; Baietti MF; Lechat B; Quarck R; Impens F; Sablina AA
    Circ Res; 2020 May; 126(10):1379-1393. PubMed ID: 32175818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intronic CRISPR Repair in a Preclinical Model of Noonan Syndrome-Associated Cardiomyopathy.
    Hanses U; Kleinsorge M; Roos L; Yigit G; Li Y; Barbarics B; El-Battrawy I; Lan H; Tiburcy M; Hindmarsh R; Lenz C; Salinas G; Diecke S; Müller C; Adham I; Altmüller J; Nürnberg P; Paul T; Zimmermann WH; Hasenfuss G; Wollnik B; Cyganek L
    Circulation; 2020 Sep; 142(11):1059-1076. PubMed ID: 32623905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delineation of LZTR1 mutation-positive patients with Noonan syndrome and identification of LZTR1 binding to RAF1-PPP1CB complexes.
    Umeki I; Niihori T; Abe T; Kanno SI; Okamoto N; Mizuno S; Kurosawa K; Nagasaki K; Yoshida M; Ohashi H; Inoue SI; Matsubara Y; Fujiwara I; Kure S; Aoki Y
    Hum Genet; 2019 Jan; 138(1):21-35. PubMed ID: 30368668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autosomal recessive Noonan syndrome associated with biallelic LZTR1 variants.
    Johnston JJ; van der Smagt JJ; Rosenfeld JA; Pagnamenta AT; Alswaid A; Baker EH; Blair E; Borck G; Brinkmann J; Craigen W; Dung VC; Emrick L; Everman DB; van Gassen KL; Gulsuner S; Harr MH; Jain M; Kuechler A; Leppig KA; McDonald-McGinn DM; Can NTB; Peleg A; Roeder ER; Rogers RC; Sagi-Dain L; Sapp JC; Schäffer AA; Schanze D; Stewart H; Taylor JC; Verbeek NE; Walkiewicz MA; Zackai EH; Zweier C; ; Zenker M; Lee B; Biesecker LG
    Genet Med; 2018 Oct; 20(10):1175-1185. PubMed ID: 29469822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rare variants in SOS2 and LZTR1 are associated with Noonan syndrome.
    Yamamoto GL; Aguena M; Gos M; Hung C; Pilch J; Fahiminiya S; Abramowicz A; Cristian I; Buscarilli M; Naslavsky MS; Malaquias AC; Zatz M; Bodamer O; Majewski J; Jorge AA; Pereira AC; Kim CA; Passos-Bueno MR; Bertola DR
    J Med Genet; 2015 Jun; 52(6):413-21. PubMed ID: 25795793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delineation of dominant and recessive forms of LZTR1-associated Noonan syndrome.
    Pagnamenta AT; Kaisaki PJ; Bennett F; Burkitt-Wright E; Martin HC; Ferla MP; Taylor JM; Gompertz L; Lahiri N; Tatton-Brown K; Newbury-Ecob R; Henderson A; Joss S; Weber A; Carmichael J; Turnpenny PD; McKee S; Forzano F; Ashraf T; Bradbury K; Shears D; Kini U; de Burca A; ; Blair E; Taylor JC; Stewart H
    Clin Genet; 2019 Jun; 95(6):693-703. PubMed ID: 30859559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical evaluation of CRISPR-based therapies for Noonan syndrome caused by deep-intronic
    Knauer C; Haltern H; Schoger E; Kügler S; Roos L; Zelarayán LC; Hasenfuss G; Zimmermann WH; Wollnik B; Cyganek L
    Mol Ther Nucleic Acids; 2024 Mar; 35(1):102123. PubMed ID: 38333672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Providing more evidence on LZTR1 variants in Noonan syndrome patients.
    Chinton J; Huckstadt V; Mucciolo M; Lepri F; Novelli A; Gravina LP; Obregon MG
    Am J Med Genet A; 2020 Feb; 182(2):409-414. PubMed ID: 31825158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oligo-astrocytoma in LZTR1-related Noonan syndrome.
    Jacquinet A; Bonnard A; Capri Y; Martin D; Sadzot B; Bianchi E; Servais L; Sacré JP; Cavé H; Verloes A
    Eur J Med Genet; 2020 Jan; 63(1):103617. PubMed ID: 30664951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic Expansion of Autosomal Dominant
    Uliana V; Ambrosini E; Taiani A; Cesarini S; Cannizzaro IR; Negrotti A; Serra W; Quintavalle G; Micale L; Fusco C; Castori M; Martorana D; Bortesi B; Belli L; Percesepe A; Pisani F; Barili V
    Genes (Basel); 2024 Jul; 15(7):. PubMed ID: 39062695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Germline gain-of-function mutations in RAF1 cause Noonan syndrome.
    Razzaque MA; Nishizawa T; Komoike Y; Yagi H; Furutani M; Amo R; Kamisago M; Momma K; Katayama H; Nakagawa M; Fujiwara Y; Matsushima M; Mizuno K; Tokuyama M; Hirota H; Muneuchi J; Higashinakagawa T; Matsuoka R
    Nat Genet; 2007 Aug; 39(8):1013-7. PubMed ID: 17603482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LZTR1: Genotype Expansion in Noonan Syndrome.
    Güemes M; Martín-Rivada Á; Ortiz-Cabrera NV; Martos-Moreno GÁ; Pozo-Román J; Argente J
    Horm Res Paediatr; 2019; 92(4):269-275. PubMed ID: 31533111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in LZTR1 drive human disease by dysregulating RAS ubiquitination.
    Steklov M; Pandolfi S; Baietti MF; Batiuk A; Carai P; Najm P; Zhang M; Jang H; Renzi F; Cai Y; Abbasi Asbagh L; Pastor T; De Troyer M; Simicek M; Radaelli E; Brems H; Legius E; Tavernier J; Gevaert K; Impens F; Messiaen L; Nussinov R; Heymans S; Eyckerman S; Sablina AA
    Science; 2018 Dec; 362(6419):1177-1182. PubMed ID: 30442762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysregulation of RAS proteostasis by autosomal-dominant LZTR1 mutation induces Noonan syndrome-like phenotypes in mice.
    Abe T; Morisaki K; Niihori T; Terao M; Takada S; Aoki Y
    JCI Insight; 2024 Nov; 9(22):. PubMed ID: 39352760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Chinese family with Noonan syndrome caused by a heterozygous variant in LZTR1: a case report and literature review.
    Zhao X; Li Z; Wang L; Lan Z; Lin F; Zhang W; Su Z
    BMC Endocr Disord; 2021 Jan; 21(1):2. PubMed ID: 33407364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noonan and LEOPARD syndrome Shp2 variants induce heart displacement defects in zebrafish.
    Bonetti M; Paardekooper Overman J; Tessadori F; Noël E; Bakkers J; den Hertog J
    Development; 2014 May; 141(9):1961-70. PubMed ID: 24718990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noonan syndrome gain-of-function mutations in NRAS cause zebrafish gastrulation defects.
    Runtuwene V; van Eekelen M; Overvoorde J; Rehmann H; Yntema HG; Nillesen WM; van Haeringen A; van der Burgt I; Burgering B; den Hertog J
    Dis Model Mech; 2011 May; 4(3):393-9. PubMed ID: 21263000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.